The European Commission says it has signed a contract on behalf of EU states with British drugmaker AstraZeneca for the supply of at least 300 million doses of its COVID-19 vaccine candidate.
The move follows an advance purchase agreement signed by Brussels with AstraZeneca earlier in August.
It is the first contract signed by the EU with a maker of potential COVID-19 vaccines.
The contract envisages an option to purchase 100 million additional doses to be distributed on a population-based pro-rata basis among the 27 EU states.
Australia has also signed a deal with AstraZeneca for vaccine supply.
The drug company is working with Oxford University on a promising vaccine candidate.